BIOMAT Database Logo BIOMAT Database Logo

Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors. 2012

U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Pharmacy Department, Faculty of Tech. and Engg., The M S University of Baroda, Vadodara 390 001,Gujarat, India.

Plasmodium falciparum cysteine protease falcipain-2 (FP-2) is a promising target for antimalarial chemotherapy and inhibition of this protease affects the growth of parasite adversely. A series of pyrido[1,2-a]pyrimidin-4-ones were synthesized and evaluated for their in vitro FP-2 inhibitory potential. Compounds (14,17) showed excellent FP-2 inhibition and can serve as lead compounds for further development of potent FP-2 inhibitors as potential antimalarial drugs.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011744 Pyrimidinones Heterocyclic compounds known as 2-pyrimidones (or 2-hydroxypyrimidines) and 4-pyrimidones (or 4-hydroxypyrimidines) with the general formula C4H4N2O. Pyrimidinone,Pyrimidone,Pyrimidones
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015853 Cysteine Proteinase Inhibitors Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. Acid Cysteine Proteinase Inhibitor,Cysteine Protease Inhibitor,Cysteine Protease Inhibitors,Cysteine Proteinase Antagonist,Cysteine Proteinase Antagonists,Cysteine Proteinase Inhibitor,Cysteine Proteinase Inhibitors, Endogenous,Cysteine Proteinase Inhibitors, Exogenous,alpha-Cysteine Protease Inhibitor,Acid Cysteine Proteinase Inhibitors,alpha-Cysteine Protease Inhibitors,Antagonist, Cysteine Proteinase,Antagonists, Cysteine Proteinase,Inhibitor, Cysteine Protease,Inhibitor, Cysteine Proteinase,Inhibitor, alpha-Cysteine Protease,Inhibitors, Cysteine Protease,Inhibitors, Cysteine Proteinase,Inhibitors, alpha-Cysteine Protease,Protease Inhibitor, Cysteine,Protease Inhibitor, alpha-Cysteine,Protease Inhibitors, Cysteine,Protease Inhibitors, alpha-Cysteine,Proteinase Antagonist, Cysteine,Proteinase Antagonists, Cysteine,Proteinase Inhibitor, Cysteine,Proteinase Inhibitors, Cysteine,alpha Cysteine Protease Inhibitor,alpha Cysteine Protease Inhibitors

Related Publications

U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.
September 2009, Bioorganic & medicinal chemistry,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Electro-Oxidative C3-Selenylation of Pyrido[1,2-a]pyrimidin-4-ones.
February 2023, Molecules (Basel, Switzerland),
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Nitrogen bridgehead compounds. 33. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 2.
August 1983, Journal of medicinal chemistry,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Synthesis of some 4H-pyrido[1,2-a]pyrimidin-4-ones investigated as antimicrobial agents.
January 1995, Farmaco (Societa chimica italiana : 1989),
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
September 1993, Farmaco (Societa chimica italiana : 1989),
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Synthesis and gastroprotective activity of 4H-pyrido[1,2-a]pyrimidin-4-ones.
January 1992, Acta physiologica Hungarica,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Synthesis of pyrido[1,2-a]pyrimidin-4-ones. Potential antihypertensive agents. III.
December 1986, Il Farmaco; edizione scientifica,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors.
July 2010, Bioorganic & medicinal chemistry,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Nitrogen bridgehead compounds. 44. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 4.
October 1984, Journal of medicinal chemistry,
U R Mane, and H Li, and J Huang, and R C Gupta, and S S Nadkarni, and R Giridhar, and P P Naik, and M R Yadav
Synthesis and biological evaluation of some novel pyrido[1,2-a]pyrimidin-4-ones as antimalarial agents.
May 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!